Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
Citeline: Trump’s MFN Executive Order More Rhetoric Than Action
The patient advocacy organization Patients for Affordable Drugs Now (P4ADNow) said that while it supports Trump’s goal, MFN pricing would be better implemented through policy like the Medicare drug price negotiation program. “This executive order is a step in the right direction, but without additional guardrails, it leaves room for pharmaceutical companies to continue gaming […]
News and Reports
Epoch Times: What to Know About Trump’s Plan to Slash Drug Prices
Merith Basey, executive director of Patients for Affordable Drugs, thinks the political moment is right for further action on drug prices. “With this administration, there is an opportunity to build on the existing progress we’ve seen and continue to fight to lower drug prices so that Americans no longer pay more than other high-income countries,” […]
News and Reports
NBC 6 South Florida: Trump signs order to cut some U.S. drug prices
NBC 6 covered yesterday’s announcement of a new Executive Order on drug prices that ties U.S. prices to those in other wealthy countries. But the proposal still leaves room for drug companies to game the system and lacks details on implementation and enforcement.
News and Reports
Washingtonian: Washington DC’s 500 Most Influential People of 2025
David Mitchell – Patients for Affordable Drugs Now – President and Founder Mitchell runs the bipartisan national organization focused on ways to lower drug prices, including marshaling patients to pressure lawmakers and testifying on Capitol Hill. Hometown: Detroit. First job: “Drugstore clerk for 67 cents per hour at 14 years of age.” What he’d tell his 18-year-old self: […]
News and Reports
Pharmaphorum: How Trump's pharma tariffs will hurt industry and patients alike
“Ninety percent of medications or prescriptions that are filled here in the US are generics,” Merith Basey, executive director of Patients for Affordable Drugs Now, told Deep Dive. “Generics are the ones, obviously, that we’re most concerned about, given that they operate on limited margins and these increases could substantially increase the cost for patients.”
Press Releases
To our Community, Today marks one hundred days into the new presidential administration. A key moment to take stock and reflect on where we are in the fight to lower drug prices for all Americans. Over the past several weeks, we’ve heard directly from nearly 1,000 people in our community – patients, family members, caregivers […]
News and Reports
Merith Basey (Patients for AffordableDrugs, Washington, DC,USA) told The Lancet Oncology that she was particularly concerned about what she called a “poison pill” part of Trump’s executive order that orders a potential change in how some drugs are costed. Under a law brought in under the Biden administration, Medicare can negotiate the price of some […]